Italy’s Angelini to buy Swiss biotech group for $1bn

Pharma group to get exclusive licence to commercialise epilepsy drug across EU, UK and Switzerland
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news